
Vu Le
Supervisory Patent Examiner (ID: 5409, Phone: (571)272-7332 , Office: P/2668 )
| Most Active Art Unit | 2613 |
| Art Unit(s) | 2615, 2621, 2613, 4157, 2899, 2624, 2668, 2713 |
| Total Applications | 831 |
| Issued Applications | 649 |
| Pending Applications | 80 |
| Abandoned Applications | 103 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16072979
[patent_doc_number] => 20200190476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => CELL SHEET HAVING FIBROSIS INHIBITORY ACTION
[patent_app_type] => utility
[patent_app_number] => 16/641874
[patent_app_country] => US
[patent_app_date] => 2018-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16641874
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/641874 | CELL SHEET HAVING FIBROSIS INHIBITORY ACTION | Aug 26, 2018 | Abandoned |
Array
(
[id] => 16451015
[patent_doc_number] => 20200360441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => POST-NATAL TRANSPLANTATION OF FACTOR VIII-EXPRESSING CELLS FOR TREATMENT OF HEMOPHILIA
[patent_app_type] => utility
[patent_app_number] => 16/638379
[patent_app_country] => US
[patent_app_date] => 2018-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638379
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638379 | POST-NATAL TRANSPLANTATION OF FACTOR VIII-EXPRESSING CELLS FOR TREATMENT OF HEMOPHILIA | Aug 22, 2018 | Abandoned |
Array
(
[id] => 16466749
[patent_doc_number] => 20200368286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => IN UTERO TRANSPLANTATION OF FACTOR VIII-EXPRESSING CELLS FOR TREATMENT OF HEMOPHILIA
[patent_app_type] => utility
[patent_app_number] => 16/638387
[patent_app_country] => US
[patent_app_date] => 2018-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17234
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638387
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638387 | IN UTERO TRANSPLANTATION OF FACTOR VIII-EXPRESSING CELLS FOR TREATMENT OF HEMOPHILIA | Aug 22, 2018 | Abandoned |
Array
(
[id] => 17421472
[patent_doc_number] => 11254917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Method of promoting spheroid formation
[patent_app_type] => utility
[patent_app_number] => 16/104533
[patent_app_country] => US
[patent_app_date] => 2018-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9586
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16104533
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/104533 | Method of promoting spheroid formation | Aug 16, 2018 | Issued |
Array
(
[id] => 13607535
[patent_doc_number] => 20180355317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => METHOD OF CULTURING NK CELLS AND KITS CONTAINING MEDIUM ADDTIONS THEREFORE
[patent_app_type] => utility
[patent_app_number] => 15/998432
[patent_app_country] => US
[patent_app_date] => 2018-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15998432
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/998432 | Method of culturing NK cells and kits containing medium additions | Aug 14, 2018 | Issued |
Array
(
[id] => 13733883
[patent_doc_number] => 20180371409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => METHOD FOR PRODUCING CILIARY MARGINAL ZONE-LIKE STRUCTURE
[patent_app_type] => utility
[patent_app_number] => 16/103629
[patent_app_country] => US
[patent_app_date] => 2018-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16103629
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/103629 | Method for producing ciliary marginal zone-like structure | Aug 13, 2018 | Issued |
Array
(
[id] => 14075003
[patent_doc_number] => 20190086389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => METHOD OF IDENTIFYING ADIPOSE STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 16/100152
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16100152
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/100152 | METHOD OF IDENTIFYING ADIPOSE STEM CELLS | Aug 8, 2018 | Abandoned |
Array
(
[id] => 13867741
[patent_doc_number] => 20190030211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => HYDROGEL SCAFFOLD FOR THREE DIMENSIONAL CELL CULTURE
[patent_app_type] => utility
[patent_app_number] => 16/050510
[patent_app_country] => US
[patent_app_date] => 2018-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16050510
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/050510 | HYDROGEL SCAFFOLD FOR THREE DIMENSIONAL CELL CULTURE | Jul 30, 2018 | Abandoned |
Array
(
[id] => 17250102
[patent_doc_number] => 11185572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-30
[patent_title] => Mesenchymal stem cells for the treatment of CNS diseases
[patent_app_type] => utility
[patent_app_number] => 16/047129
[patent_app_country] => US
[patent_app_date] => 2018-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 49
[patent_no_of_words] => 18074
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16047129
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/047129 | Mesenchymal stem cells for the treatment of CNS diseases | Jul 26, 2018 | Issued |
Array
(
[id] => 13590667
[patent_doc_number] => 20180346882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => ISOLATED POPULATIONS OF ADULT RENAL CELLS AND METHODS OF ISOLATING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/045784
[patent_app_country] => US
[patent_app_date] => 2018-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16045784
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/045784 | Isolated populations of adult renal cells and methods of isolating and using same | Jul 25, 2018 | Issued |
Array
(
[id] => 13524539
[patent_doc_number] => 20180313812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => METASTATIC CANCER DIAGNOSIS VIA DETECTING pH-DEPENDENT ACTIVATION OF AUTOPHAGY IN INVASIVE CANCER CELLS
[patent_app_type] => utility
[patent_app_number] => 16/030066
[patent_app_country] => US
[patent_app_date] => 2018-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16030066
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/030066 | METASTATIC CANCER DIAGNOSIS VIA DETECTING pH-DEPENDENT ACTIVATION OF AUTOPHAGY IN INVASIVE CANCER CELLS | Jul 8, 2018 | Abandoned |
Array
(
[id] => 18666492
[patent_doc_number] => 11773370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Stem cell-derived skin precursor cell culture medium and preparation method therefor
[patent_app_type] => utility
[patent_app_number] => 16/627671
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 7846
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627671
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/627671 | Stem cell-derived skin precursor cell culture medium and preparation method therefor | Jul 1, 2018 | Issued |
Array
(
[id] => 19578743
[patent_doc_number] => 12144825
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-19
[patent_title] => Cellular immunotherapy for repetitive administration
[patent_app_type] => utility
[patent_app_number] => 16/625678
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 68843
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625678
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625678 | Cellular immunotherapy for repetitive administration | Jul 1, 2018 | Issued |
Array
(
[id] => 19043791
[patent_doc_number] => 11932877
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => Human fibrolamellar hepatocellular carcinomas (hFL-HCCs)
[patent_app_type] => utility
[patent_app_number] => 16/011534
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 25949
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16011534
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/011534 | Human fibrolamellar hepatocellular carcinomas (hFL-HCCs) | Jun 17, 2018 | Issued |
Array
(
[id] => 15524751
[patent_doc_number] => 20200054681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING A CLINICAL CONDITION THROUGH THE USE OF HEMATOPOIETIC STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 16/487609
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15619
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -53
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487609
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/487609 | Compositions and methods for treating a clinical condition through the use of hematopoietic stem cells | Jun 14, 2018 | Issued |
Array
(
[id] => 16925466
[patent_doc_number] => 11046929
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Induction medium and methods for stem cell culture and therapy
[patent_app_type] => utility
[patent_app_number] => 16/001300
[patent_app_country] => US
[patent_app_date] => 2018-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7379
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16001300
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/001300 | Induction medium and methods for stem cell culture and therapy | Jun 5, 2018 | Issued |
Array
(
[id] => 13899203
[patent_doc_number] => 20190038806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => BONE-LIKE PROSTHETIC IMPLANTS
[patent_app_type] => utility
[patent_app_number] => 15/996963
[patent_app_country] => US
[patent_app_date] => 2018-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996963
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/996963 | Bone-like prosthetic implants | Jun 3, 2018 | Issued |
Array
(
[id] => 13586701
[patent_doc_number] => 20180344899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => ENHANCEMENT OF NUCLEUS PULPOSUS REGENERATION BY ENHANCED PERFUSION OF PERISPINAL AREA BY COMBINATION DRUG, GENE AND CELLULAR THERAPIES
[patent_app_type] => utility
[patent_app_number] => 15/996182
[patent_app_country] => US
[patent_app_date] => 2018-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996182
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/996182 | ENHANCEMENT OF NUCLEUS PULPOSUS REGENERATION BY ENHANCED PERFUSION OF PERISPINAL AREA BY COMBINATION DRUG, GENE AND CELLULAR THERAPIES | May 31, 2018 | Abandoned |
Array
(
[id] => 20201724
[patent_doc_number] => 12404493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-02
[patent_title] => Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cells
[patent_app_type] => utility
[patent_app_number] => 15/994302
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 39603
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15994302
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/994302 | Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cells | May 30, 2018 | Issued |
Array
(
[id] => 16853490
[patent_doc_number] => 20210154235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => STROMAL STEM CELL THERAPEUTICS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/614278
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -67
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16614278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/614278 | STROMAL STEM CELL THERAPEUTICS AND METHODS OF USE | May 29, 2018 | Pending |